-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Alzheimer's disease (AD) is a progressive neurological disease that causes brain shrinkage (atrophy) and brain cell death
To this end, neurologists from the University of Washington in the United States analyzed the longitudinal data of more than 10,000 elderly people without cognitive impairment, and modeled the five-year AD dementia risk using survival analysis, aiming to find a calculation method
The researchers built a demographic model and validated it on independent data to predict an area (AUC) of 0.
In summary, the study developed and validated an adaptive tool to calculate the absolute risk
References:
A flexible modeling approach for biomarker-based computation of absolute risk of Alzheimer's disease dementia.